Advertisement

Index by author

February 01, 1994; Volume 45,Issue 2

  1. Narimatsu, S

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  2. Narumoto, N

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  3. Nelson, D L

    1. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
      M P Johnson, R J Loncharich, M Baez and D L Nelson
      Molecular Pharmacology February 1994, 45 (2) 277-286;

  4. Nemec, J

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  5. Neve, K A

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;
Back to top

In this issue

Advertisement